Company Announcements
Securities allotted from Block Listing
Related Companies
By LSE RNS
For immediate release
17 March 2017
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Securities allotted from Block Listing
MedicX Fund Limited (LSE: MXF), announces in accordance with Listing Rule 3.5.6R the number of securities allotted over the six month period pursuant to the block listing of 23,981,109 ordinary shares of no par value admitted to The Official List of the UK Listing Authority on 16 September 2016.
|
Name of applicant: |
MedicX Fund Limited |
|||
|
Name of scheme: |
Block Listing |
|||
|
Period of return: |
From: |
16/09/2016 |
To: |
18/03/2017 |
|
Balance of unallotted securities under scheme(s) from previous return: |
Nil |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
16 September 2016 - 23,981,109 28 February 2017 - 17,769,108 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
23/09/2016 - 1,000,000 28/09/2016 - 1,000,000 04/10/2016 - 3,000,000 20/10/2016 - 1,250,000 26/10/2016 - 1,500,000 17/11/2016 - 1,000,000 18/11/2016 - 1,000,000 28/11/2016 - 1,150,000 19/12/2016 - 1,000,000 05/01/2017 - 2,750,000 27/01/2017 - 1,600,000 09/02/2017 - 2,000,000 17/02/2017 - 5,000,000 Total allotted - 23,250,000 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
Total remaining - 18,500,217 |
|||
|
Name of contact: |
Alan Pennell |
|
Telephone number of contact: |
0203 142 4813 |
- End -
For further information please contact:
MedicX Fund +44 (0) 1481 723 450
David Staples, Chairman
Octopus Healthcare Group +44 (0) 20 3142 4820
Mike Adams, Chief Executive Officer
Canaccord Genuity +44 (0) 20 7523 8000
Andrew Zychowski/Helen Goldsmith
Buchanan +44 (0) 20 7466 5000
Charles Ryland/Vicky Hayns
Information on MedicX Fund Limited
MedicX Fund Limited ("MXF", "the Fund" or "the Company", or together with its subsidiaries, "the Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom and Ireland, listed on the London Stock Exchange, with a portfolio comprising 154 properties.
The Investment Adviser to the Company is Octopus Healthcare Adviser Ltd, which is part of the Octopus Healthcare group. Octopus Healthcare invests in and develops properties as well as creating partnerships to deliver innovative healthcare buildings to improve the health, wealth and wellbeing of the UK. It currently manages over £1 billion of healthcare investments across a number of platforms, with a focus on five core areas: GP surgeries, care homes, special education schools, retirement housing and private hospitals. Octopus Healthcare is part of the Octopus group, a fast-growing UK fund management business with leading positions in several specialist sectors including healthcare property, energy, property finance and smaller company investing. Octopus manages £6 billion of funds for more than 50,000 retail and institutional investors.
Octopus Healthcare Adviser Ltd is authorised and regulated by the Financial Conduct Authority.
The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.
The Company's Legal Entity Identifier is 2138008POF35FTNFCB25.
This information is provided by RNS
You are here: news > regulatory news
10 Lower Thames St,
London EC3R 6EN